Akers Biosciences Inc

Entry into a Material Definitive Agreement

Termination of a Material Definitive Agreement

General form for quarterly reports under Section 13 or 15(d)

Termination of a Material Definitive Agreement

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d) (amendment)

Annual report pursuant to Section 13 or 15(d)

Notification of late filing of Form 10-K

Changes in Registrant's Certifying Accountant

Notice of Effectiveness

Correspondence with the SEC

Registration statement under Securities Act of 1933

Letter from the SEC

Entry into a Material Definitive Agreement

Draft registration statement (confidential submission)

Entry into a Material Definitive Agreement

Prospectus Supplement for Primary Offering

Notice of Effectiveness

General form for quarterly reports under Section 13 or 15(d)

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Notification of late filing of Form 10-Q

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Definitive Proxy Statement

Preliminary Proxy Statement

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Entry into a Material Definitive Agreement

Registration statement under Securities Act of 1933

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Letter from the SEC

Entry into a Material Definitive Agreement

Financial Statements and Exhibits

Rule 506(b) provides a "safer harbor" for a private offering

Entry into a Material Definitive Agreement

General form for quarterly reports under Section 13 or 15(d)

Correspondence with the SEC

Notification of late filing of Form 10-Q

Letter from the SEC

Material Modifications to Rights of Security Holders

Required Information in Proxy Statement

General form for quarterly reports under Section 13 or 15(d)

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

No description available

Annual Report Scanned (Paper)

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Preliminary Proxy Statement

Notification of late filing of Form 10-K

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Regulation FD Disclosure

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

General form for quarterly reports under Section 13 or 15(d)

Annual Report Scanned (Paper)

Definitive Proxy Statement

1.01,3.02,8.01,9.01

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Correspondence with the SEC

Registration statement under Securities Act of 1933 (amendment)

Definitive Proxy Statement

Letter from the SEC

Registration statement under Securities Act of 1933

Preliminary Proxy Statement

06b

06b

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Additional Information for Proxy Statement/ Votes

Annual Report Scanned (Paper)

Definitive Proxy Statement

Preliminary Proxy Statement

General form for quarterly reports under Section 13 or 15(d)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Prospectus Supplement for Primary Offering

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

06b

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Correspondence with the SEC

Correspondence with the SEC

Registration statement under Securities Act of 1933 (amendment)

Letter from the SEC

Written communication about a business combination transaction (Rule 425)

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Silverman Joshua

Silverman Joshua

Ehrlichman Yossef

Fagan Charles Todd

Voss Chelsea Sierra

Voss Chelsea Sierra

White Billy Joe

Bernstein Bruce

Friscia Stephen

Glass Mitchell

Silverman Joshua

Voss Chelsea Sierra

Voss Chelsea Sierra

PharmaCyte Biotech, Inc.

White Billy Joe

Glass Mitchell

RAUCH GARY M

Silverman Joshua

Friscia Stephen